A Study To Investigate The Safety And Efficacy Properties Of PF-00547659 In Patients With Active Ulcerative Colitis
NCT00928681 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 80
Last updated 2009-06-26
Summary
study to investigate the safety and efficacy properties of PF-00547659 in patients with active ulcerative colitis
Conditions
- Colitis, Ulcerative
Interventions
- BIOLOGICAL
-
Single dose-group A
PF-00547659, single iv dose
- BIOLOGICAL
-
Single dose-group A
PF-00547659, single iv dose
- BIOLOGICAL
-
Multiple dose- Group B
PF-00547659, multiple dose
- BIOLOGICAL
-
Single dose-group A
PF-00547659, single iv dose
- BIOLOGICAL
-
Multiple dose- Group B
PF-00547659, multiple dose
- BIOLOGICAL
-
Single dose-group A
PF-00547659, single dose
- BIOLOGICAL
-
Single dose-group A
PF-00547659, single dose
- BIOLOGICAL
-
Single dose-group A
PF-00547659, single dose
- BIOLOGICAL
-
Single dose-group A
PF-00547659, single dose
- BIOLOGICAL
-
Multiple dose-Group B
PF-00547659, multiple dose
- BIOLOGICAL
-
Multiple dose- Group B
PF-00547659, multiple dose
- BIOLOGICAL
-
Multiple dose- Group B
PF-00547659, multiple dose
- BIOLOGICAL
-
Multiple dose- Group B
PF-00547659, multiple dose
- BIOLOGICAL
-
Multiple dose- Group B
PF-00547659, multiple dose
- BIOLOGICAL
-
Multiple dose-Group B
PF-00547659, multiple dose
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
Pfizer CT.gov Call Center · Pfizer
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- DOUBLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 70 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2005-09-30
- Primary Completion
- 2008-04-30
- Completion
- 2008-10-31
Countries
- Belgium
- Czechia
- Denmark
- Germany
- Norway
- Slovakia
- Spain
Study Locations
More Related Trials
-
Efficacy and Safety of SAR339658 in Patients With Moderate to Severe Ulcerative Colitis
NCT01659138 ·Status: TERMINATED ·Phase: PHASE2
-
Safety, Efficacy, Pharmacokinetic and Pharmacodynamic Study of GLPG0974 in Subjects With Ulcerative Colitis
NCT01829321 ·Status: COMPLETED ·Phase: PHASE2
-
Single Ascending Dose and Multiple Ascending Dose Study in Healthy Participants and Proof of Mechanism Study in Patients With Ulcerative Colitis
NCT02864264 ·Status: TERMINATED ·Phase: PHASE1
-
Safety, Tolerability, Efficacy and Dose-response of GSK2831781 in Ulcerative Colitis
NCT03893565 ·Status: TERMINATED ·Phase: PHASE2
-
A Study Of PF-00547659 In Patients With Moderate To Severe Ulcerative Colitis
NCT01620255 ·Status: COMPLETED ·Phase: PHASE2
-
Safety and Efficacy of PBF-677 in Ulcerative Colitis Patients
NCT03773952 ·Status: COMPLETED ·Phase: PHASE2
-
Filgotinib in Long-Term Extension Study of Adults With Ulcerative Colitis
NCT02914535 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Evaluate the Efficacy and Safety of rhuMAb Beta7 in Patients With Moderate to Severe Ulcerative Colitis
NCT01336465 ·Status: COMPLETED ·Phase: PHASE2
-
An Investigation of Oral BT051 in Subjects With Moderately to Severely Active Ulcerative Colitis (UC)
NCT05084261 ·Status: COMPLETED ·Phase: PHASE1
-
Safety and Pharmacokinetic Study of PF-06651600 in Healthy Volunteers
NCT02309827 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics (PK) of RO7837195 in Participants With Moderately to Severely Active Ulcerative Colitis (UC)
NCT06979336 ·Status: RECRUITING ·Phase: PHASE2
-
Safety and Efficacy of Deucravacitinib in Participants With Moderate to Severe Ulcerative Colitis
NCT03934216 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of Safety and Effectiveness of JNJ-54781532 in Patients With Moderately to Severely Active Ulcerative Colitis
NCT01959282 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy and Safety of GLPG1205 in Subjects With Active Ulcerative Colitis
NCT02337608 ·Status: COMPLETED ·Phase: PHASE2
-
Study To Evaluate The Efficacy And Safety Of Oral PF-06651600 And PF-06700841 In Subjects With Moderate To Severe Crohn's Disease
NCT03395184 ·Status: COMPLETED ·Phase: PHASE2
-
Confirmatory Clinical Study in Active Ulcerative Colitis
NCT07296315 ·Status: RECRUITING ·Phase: PHASE2
-
A Study To Investigate The Safety And Efficacy Of CP- 690,550 In Patients With Moderate And Severe Ulcerative Colitis.
NCT00787202 ·Status: COMPLETED ·Phase: PHASE2
-
Study To Test Whether PF-00547659 Is Safe And Improves Disease Symptoms In Patients With Crohn's Disease
NCT01276509 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Investigate Efficacy and Safety of SAR441566 in Patients With Ulcerative Colitis
NCT06867094 ·Status: RECRUITING ·Phase: PHASE2
-
Effect of GSK1399686 in Patients With Mild to Moderately Active Ulcerative Colitis
NCT01036022 ·Status: COMPLETED ·Phase: PHASE2
-
A Study Evaluating the Effects of Filgotinib in Children and Teenagers With Ulcerative Colitis
NCT06865417 ·Status: RECRUITING ·Phase: PHASE3
-
Food Supplementation With VSL#3 as a Support to Standard Pharmaceutical Therapy in Ulcerative Colitis
NCT00951548 ·Status: COMPLETED ·Phase: NA
-
Prospective Observational Study of Effectiveness and Safety of Filgotinib in Participants With Ulcerative Colitis (UC)
NCT05817942 ·Status: ACTIVE_NOT_RECRUITING
-
A Study of JNJ-77242113 in Participants With Moderately to Severely Active Ulcerative Colitis
NCT06049017 ·Status: COMPLETED ·Phase: PHASE2
-
Safety and Pharmacokinetic Study of PF-06651600 in Japanese Healthy Volunteers
NCT03232905 ·Status: COMPLETED ·Phase: PHASE1